Cytognos特约代理商|CYT-MM-MRD-CE-IV

Incomplete DJH Rearrangements

and minimal residual disease (MRD). Although several different sensitive protocols are now available for PCR analysis of IgH genes, they are frequently hampered owing to the high rate of somatic hypermutation present in multiple myeloma (MM). We recently

Real-Time Polymerase Chain Reaction of Immunoglobulin Rearrangements for Quantitative Evaluation of Minimal Residual Disease in Myeloma

The evaluation of minimal residual disease (MRD) is critical in the evaluation of treatments aimed at maximal cytoreduction in multiple myeloma (MM). Qualitative evaluation of MRD now has a 10-yr-long history, but it remains a relatively

Two-hybrid analysis of genetic

protein sequences suggested residues that may be important for specific interactions with certain Cdis.Second,Cdi3,Drosophila Cyclin D,interacted much more strongly with human Cdk4 than with any of the other Cdks in the panel including the Drosophila Cdks